Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus
Enrolling by invitation · Phase 3 · NCT06475742
Conditions: Lupus Erythematosus, Systemic
At a glance
- Research payments reported, 2025
- $117,661
- U.S. investigators named
- 10
- Sites paid
- 5
- Planned or actual enrollment
- 680
About the trial
- Sponsor
- Viatris Innovation GmbH
- Tested
- Cenerimod (drug)
- Dates
- Started 2024-07-30; completion 2032-09
- Results posted
- Not yet
The goal of this clinical study is to learn about the long-term safety and tolerability of cenerimod in adult patients with moderate to severe symptoms of systemic lupus erythematosus. The main questions it aims to answer are: * Whether cenerimod causes any adverse effects ('side effects') when given on top of drugs already being given for systemic lupus erythematosus. * How well cenerimod works to reduce symptoms of systemic lupus erythematosus when taken for up to 5 years. Participants taking part in this study will have already taken part in another study, where they received either cenerimod or placebo (look-alike substance containing no active drug) for 1 year. In this clinical study…
From ClinicalTrials.gov, last updated 2026-09-11. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Idorsia Pharmaceuticals US Inc reported $117,661 in research payments for this study in 2025 (67 payments).
Products named: Cenerimod
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Jorge Amaya, M.D. General Practice · Miami, FL
- Robert W. Levin, M.D. Rheumatology · Clearwater, FL
- Alvaro J. Ocampo, MD, MPH General Practice · Coral Gables, FL
- Adil A. Fatakia, M.D. ENT (Otolaryngology) · Marrero, LA
- Enrique A. Mendez, M.D. Rheumatology · Lake Charles, LA
- Amarilis J. Perez Rheumatology · Caguas, PR
- Karina Vila-rivera, M.D. Rheumatology · San Juan, PR
- Sabeen Najam, MD Rheumatology · Baytown, TX
- Philip A. Waller, M.D. Rheumatology · Houston, TX
- Wajeeha Yousaf, MD Rheumatology · Houston, TX
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Accurate Clinical Research Inc. $30,927
- Southcoast Research Center, Inc $28,814
- Advarra, Inc. $24,665
- Accurate Clinical Management, LLC $17,255
- Clinical Research of West Florida, Inc. $16,000
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.